| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.06美元,归母净利润-463.17万美元,同比去年增长-72.95%
|
| 2025-11-12 |
股东大会：
将于2025-12-18召开股东大会
会议内容 ▼▲
- 1.Election of six directors;
2.Approval to amend the Corporation’s Restated Certificate of Incorporation, increasing the number of authorized shares of Common Stock from 100,000,000 shares to 125,000,000;
3.Ratification of the appointment of CBIZ CPAs P.C. as the Company’s independent auditors for the fiscal year ending December 31, 2025;
4.Such other business as may legally come before the Meeting and any adjournments or postponements thereof.
|
| 2025-11-12 |
详情>>
股本变动：
变动后总股本7862.89万股
|
| 2025-10-22 |
详情>>
内部人交易：
BP4 S.r.l.共交易3笔
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-0.04美元,归母净利润-347.77万美元,同比去年增长-185.79%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.02美元,归母净利润-199.46万美元,同比去年增长-38.46%
|
| 2025-04-15 |
详情>>
业绩披露：
2024年年报每股收益-0.06美元,归母净利润-471.36万美元,同比去年增长31.97%
|
| 2024-11-15 |
财报披露：
美东时间 2024-11-15 盘前发布财报
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.03美元,归母净利润-267.81万美元,同比去年增长46.33%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.02美元,归母净利润-121.69万美元,同比去年增长65.47%
|
| 2024-06-05 |
股东大会：
将于2024-07-16召开股东大会
会议内容 ▼▲
- 1.Election of seven directors;
2.Ratification of the appointment of Marcum LLP as the Company's independent auditors for the fiscal year ending December 31, 2024;
3.Such other business as may legally come before the Meeting and any adjournments or postponements thereof.
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.02美元,归母净利润-144.05万美元,同比去年增长-10.16%
|
| 2024-03-29 |
详情>>
业绩披露：
2023年年报每股收益-0.1美元,归母净利润-692.91万美元,同比去年增长20.41%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.07美元,归母净利润-499.03万美元,同比去年增长25.87%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.05美元,归母净利润-352.4万美元,同比去年增长25.97%
|
| 2023-05-01 |
股东大会：
将于2023-06-28召开股东大会
会议内容 ▼▲
- 1.Election of six (6) directors;
2.Approval of an amendment to the Company’s 2020 Equity Incentive Plan to increase the number of shares of Common Stock which may be issued from 4,000,000 shares to 11,500,000 shares.
3.Ratification of the appointment of Marcum LLP as the Company's independent auditors for the fiscal year ending December 31, 2023;
4.Such other business as may legally come before the Meeting and any adjournments or postponements thereof.
|
| 2023-02-28 |
复牌提示：
2023-02-27 11:00:22 停牌，复牌日期 2023-02-27 11:05:22
|
| 2022-04-29 |
股东大会：
将于2022-06-13召开股东大会
会议内容 ▼▲
- 1.Election of seven (7) directors;
2.Approval of a non-binding advisory resolution relating to compensation of the Company’s Named Executive Officers;
3.Ratification of the appointment of Friedman LLP as the Company's independent auditors for the fiscal year ending December 31, 2022;
4.Such other business as may legally come before the Meeting and any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-11召开股东大会
会议内容 ▼▲
- 1.Election of six (6) directors;
2.Approval of an amendment to the Company’s Restated Certificate of Incorporation increasing the number of authorized shares of Common Stock from 85,000,000 shares to 100,000,000 shares;
3.Approval of the Company’s Amended and Restated 2020 Equity Incentive Plan, among other things, increasing the number of shares from 2,000,000 to 4,000,000;
4.Ratification of the appointment of Friedman LLP as the Company's independent auditors for the fiscal year ending December 31, 2021;
5.Such other business as may legally come before the Meeting and any adjournments or postponements thereof.
|
| 2020-10-26 |
股东大会：
将于2020-12-08召开股东大会
会议内容 ▼▲
- 1.Election of six (6) directors.
2.Approval to amend the Company’s Restated Certificate of Incorporation increasing the number of authorized shares of Common Stock from 75,000,000 shares to 85,000,000
3.Approval of the Company’s 2020 Equity Incentive Plan
4.Ratification of the appointment of Friedman LLP as the Company's independent auditors for the fiscal year ending December 31, 2020;
5.Such other business as may legally come before the Meeting and any adjournments or postponements thereof.
|
| 2019-11-05 |
股东大会：
将于2019-12-17召开股东大会
会议内容 ▼▲
- 1.Election of six (6) directors.
2.Approval to amend the Corporation’s Restated Certificate of Incorporation increasing the number of authorized shares of Common Stock from 50,000,000 shares to 75,000,000
3.Approval of a non-binding advisory resolution relating to compensation of the Company’s Named Executive Officers
4.Approval of a non-binding advisory resolution relating to the frequency of holding non-binding advisory resolutions relating to the compensation of the Company’s Named Executive Officers
5.Ratification of the appointment of Friedman LLP as the Company's independent auditors for the fiscal year ending December 31, 2019;
6.Such other business as may legally come before the meeting and any adjournments or postponements thereof.
|
| 2018-04-30 |
股东大会：
将于2018-05-30召开股东大会
会议内容 ▼▲
- 1.Election of six (6) directors.
2.Advisory approval of the appointment of Friedman LLP as the Company's independent auditors for the fiscal year ending December 31, 2018.
3.Such other business as may legally come before the meeting and any adjournments or postponements thereof.
|
| 2017-04-12 |
股东大会：
将于2017-05-23召开股东大会
会议内容 ▼▲
- 1.Election of five (5) directors.
2.Advisory approval of the appointment of Friedman LLP as the Company's independent auditors for the fiscal year ending December 31, 2017.
3.Such other business as may legally come before the meeting and any adjournments or postponements thereof.
|
| 2016-04-15 |
股东大会：
将于2016-05-25召开股东大会
会议内容 ▼▲
- 1.Election of five (5) directors.
2.Approval of amendments to the 2011 Stock Option Plan to: (i) change the name of the plan to the “Milestone Scientific Inc. 2011 Equity Compensation Plan”; (ii) provide for awards of shares of the Company’s common stock; and (iii) increase the maximum number of shares which may be issued thereunder from 2,000,000 to 4,000,000.
3.Approval of the non-binding advisory resolution relating to the compensation of the Company’s Named Executive Officers.
4.Advisory approval of the appointment of Baker Tilly Virchow Krause, LLP as the Company’s independent auditors for the fiscal year ending December 31, 2016.
5.Any and all matters incident to the foregoing, and such other business as may legally come before the meeting and any adjournments or postponements thereof.
|